ES525553A0 - Procedimiento para la fabricacion de derivados peptidicos inhibidores de proteasas acidas - Google Patents

Procedimiento para la fabricacion de derivados peptidicos inhibidores de proteasas acidas

Info

Publication number
ES525553A0
ES525553A0 ES525553A ES525553A ES525553A0 ES 525553 A0 ES525553 A0 ES 525553A0 ES 525553 A ES525553 A ES 525553A ES 525553 A ES525553 A ES 525553A ES 525553 A0 ES525553 A0 ES 525553A0
Authority
ES
Spain
Prior art keywords
group
formula
procedure
manufacture
statyl2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES525553A
Other languages
English (en)
Other versions
ES8405365A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Sanofi SA
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA, Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Sanofi SA
Publication of ES8405365A1 publication Critical patent/ES8405365A1/es
Publication of ES525553A0 publication Critical patent/ES525553A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0227—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the (partial) peptide sequence -Phe-His-NH-(X)2-C(=0)-, e.g. Renin-inhibitors with n = 2 - 6; for n > 6 see C07K5/06 - C07K5/10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/86—Renin inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES525553A 1982-08-17 1983-08-17 Procedimiento para la fabricacion de derivados peptidicos inhibidores de proteasas acidas Granted ES525553A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8214219A FR2531951A1 (fr) 1982-08-17 1982-08-17 Derives peptidiques inhibiteurs de proteases acides, procede pour leur preparation et medicaments qui en contiennent

Publications (2)

Publication Number Publication Date
ES8405365A1 ES8405365A1 (es) 1984-06-01
ES525553A0 true ES525553A0 (es) 1984-06-01

Family

ID=9276914

Family Applications (1)

Application Number Title Priority Date Filing Date
ES525553A Granted ES525553A0 (es) 1982-08-17 1983-08-17 Procedimiento para la fabricacion de derivados peptidicos inhibidores de proteasas acidas

Country Status (13)

Country Link
US (1) US4481192A (es)
EP (1) EP0104964B1 (es)
JP (1) JPH0680076B2 (es)
AT (1) ATE28078T1 (es)
AU (1) AU563230B2 (es)
CA (1) CA1245632A (es)
DE (1) DE3372289D1 (es)
DK (1) DK372083A (es)
ES (1) ES525553A0 (es)
FR (1) FR2531951A1 (es)
GR (1) GR79635B (es)
NZ (1) NZ205296A (es)
ZA (1) ZA835962B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1039267B (de) * 1953-12-19 1958-09-18 Schenk Bau G M B H Vorrichtung zum Erzeugen gerichteter Schwingungen mit umlaufender Unwucht
US4595677A (en) * 1982-12-03 1986-06-17 Ciba-Geigy Corporation Substituted tetrapeptides
EP0114993B1 (en) * 1982-12-27 1990-05-16 Merck & Co. Inc. Renin inhibitory tripeptides
DK110285A (da) * 1984-03-12 1985-09-13 Pfizer Polypeptider og polypeptidderivater indeholdende statin eller derivater deraf og farmaceutiske praeparater
FR2564844A1 (fr) * 1984-05-25 1985-11-29 Sanofi Sa Nouveaux peptides derives de la statine, procede d'obtention et compositions pharmaceutiques les contenant
FR2565584B1 (fr) * 1984-06-06 1986-10-17 Sanofi Sa Derives d'acide heptanoique, leur procede de preparation ainsi que leur utilisation
FR2577226B1 (fr) * 1985-02-12 1990-06-15 Sanofi Sa Analogues de pepstatine inhibiteurs de la renine et des proteases acides
CA1286846C (en) * 1985-02-12 1991-07-23 Catherine Cazaubon Peptide derivatives which inhibit renin and acid proteases
FR2577225B1 (fr) * 1985-02-12 1987-08-28 Sanofi Sa Derives peptidiques inhibiteurs de la renine et des proteases acides
DE3512128A1 (de) * 1985-04-03 1986-10-09 Merck Patent Gmbh, 6100 Darmstadt Peptide
US4777286A (en) * 1985-06-18 1988-10-11 The Upjohn Company Certain aryl or hetero-hydroxamic acid esters useful as renin inhibitors
US4599198A (en) * 1985-08-02 1986-07-08 Pfizer Inc. Intermediates in polypeptide synthesis
US4906613A (en) * 1985-11-05 1990-03-06 Schering Corporation Antiglaucoma compositions and methods
US4743585A (en) * 1986-11-21 1988-05-10 Warner-Lambert Company Renin inhibitors
US4804743A (en) * 1987-01-29 1989-02-14 Warner-Lambert Copmany Proline-containing renin inhibitors
FR2646353B1 (fr) * 1989-04-27 1994-02-25 Sanofi Utili sation de peptides contenant de la statine pour la preparation de medicaments utiles pour le traitement des maladies virales
US5688770A (en) * 1989-12-14 1997-11-18 Schering Corporation Antiglaucoma compositions and methods
CA2100171A1 (en) * 1991-01-31 1992-08-01 Kazumi Shiosaki Endothelin converting enzyme inhibitors
WO1995005192A1 (en) * 1993-08-13 1995-02-23 Merck & Co., Inc. SUBSTITUTED KETONE DERIVATIVES AS INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
AU4104996A (en) * 1994-10-20 1996-05-15 Nzym, Inc. Pepstatin-derivatives for the treatment and detection of fungal infections
US5798442A (en) * 1995-04-21 1998-08-25 Merck Frosst Canada, Inc. Peptidyl derivatives as inhibitors of pro-apoptotic cysteine proteinases
EP2113510A1 (en) 2008-04-30 2009-11-04 Freie Universität Berlin Pepstatin A derivatives

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3840516A (en) * 1969-06-13 1974-10-08 Microbial Chem Res Found Biologically active substance,pepstatin and production processes thereof
JPS5022116B1 (es) * 1970-04-28 1975-07-28
DK132899C (da) * 1972-04-07 1976-07-26 Takeda Chemical Industries Ltd Fremgangsmade til fremstilling af de proteaseinhiberende stoffer pepsinostreptiner eller salte deraf
DE2506601C3 (de) * 1974-02-28 1980-12-11 Sanraku-Ocean Co., Ltd., Tokio Tetrapeptide und Verfahren zu ihrer Herstellung
JPS52108925A (en) * 1976-03-09 1977-09-12 Sumitomo Chem Co Ltd Protease inhibitor
JPS5938220B2 (ja) * 1976-12-16 1984-09-14 住友化学工業株式会社 ペプタイド
JPS54163826A (en) * 1978-06-12 1979-12-26 Sumitomo Chemical Co Hypertension treating agent
JPS56147718A (en) * 1980-04-16 1981-11-16 Sumitomo Chem Co Ltd Acidic protease inhibitor and antiulcerative composed thereof
JPS56164153A (en) * 1980-05-20 1981-12-17 Eisai Co Ltd Novel desacylvalypepsidin derivative and its preparation

Also Published As

Publication number Publication date
US4481192A (en) 1984-11-06
FR2531951B1 (es) 1985-01-18
JPS5989649A (ja) 1984-05-23
ES8405365A1 (es) 1984-06-01
EP0104964A1 (fr) 1984-04-04
EP0104964B1 (fr) 1987-07-01
AU563230B2 (en) 1987-07-02
DK372083A (da) 1984-02-18
GR79635B (es) 1984-10-31
DK372083D0 (da) 1983-08-15
NZ205296A (en) 1987-10-30
DE3372289D1 (en) 1987-08-06
JPH0680076B2 (ja) 1994-10-12
FR2531951A1 (fr) 1984-02-24
ZA835962B (en) 1984-10-31
ATE28078T1 (de) 1987-07-15
AU1787483A (en) 1984-02-23
CA1245632A (fr) 1988-11-29

Similar Documents

Publication Publication Date Title
ES525553A0 (es) Procedimiento para la fabricacion de derivados peptidicos inhibidores de proteasas acidas
RU94046295A (ru) L-аспартил-d- альфа -аминоалканоил-(s)-n-d-алкилбензиламиды, используемые в качестве искусственных подслащивающих агентов, пищевой состав, способ подслащивания пищевого состава
DE3166150D1 (en) N-(vinblastinoyl-23) derivatives of amino acids and peptides and their preparation
DE69627704D1 (en) Protegrine
FR2281162A1 (fr) Aminoacides n-acyles et derives d'acides amines n-acyles comme agents gelifiants
IL104716A (en) 7-1-oxo-2- (substituted mercapto)-3- phenylpropyl) amino| octahydro-6-pyrido £2, 1-a| benzazepine- 4-carboxylic acid derivatives and analogs, their preparation and pharmaceutical compositions containing them for inhibiting enkephalinase and ace
DE68916932D1 (de) Antimikrobielle peptide, zusammensetzungen, die diese enthalten, und verwendungen daraus.
DE69429176D1 (en) Protegrine
NO940299D0 (no) peptid med organbestkyttende aktivitet
ES2137620T3 (es) Ligandos peptidicos para la region constante de las inmunoglobulinas.
IE852596L (en) Peptides active on the cns
JPS5594934A (en) Peptide type polymer and pharmaceutic composition containing it
DE69102069D1 (de) 5-aminosalicylsäurederivate zur therapie chronisch entzündlicher baucherkrankungen.
ATE70454T1 (de) Vincristin enthaltendes produkt.
ATE27822T1 (de) Hexapeptid, verfahren zur herstellung und pharmazeutische zusammensetzungen hieraus.
TH27915B (th) การปรับปรุงความสามารถที่จะทนทานได้ของกรด(สูตร)- อะมิโนที่ออกฤทธิ์ทางเภสัชกรรม
ES2054208T3 (es) Nuevos derivados gem-diaminicos y su empleo en la sintesis de peptidos retro-inversos.
TH14322EX (th) สารประกอบไทรไซคลิคที่ต่อต้านฤทธิ์ของแทคิควินีน, การเตรียมและสูตรผสมทางเภสัชกรรมที่ประกอบด้วย สารประกอบนั้น
KR830004213A (ko) 생물학적 활성을 가지는 펲타이드의 제조방법

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401